Efficacy of Mother's Time in Ethiopia

NCT05806463 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 328

Last updated 2024-01-09

No results posted yet for this study

Summary

Mother's Time is an evidence-based cognitive behavioral therapy (CBT) tool designed to support postpartum women experiencing mild to moderate symptoms of stress, depression or anxiety. The intervention is designed for use by Ethiopian community health workers (CHWs) and includes CBT exercises and discussion on topics relating to family planning, such as planning for the future, speaking to the husband, and considering potential side effects.

The primary objective of this research is to test the efficacy of Mother's Time, on mild to moderate symptoms of postpartum stress, anxiety, and depression as well as associated behavioral and social barriers to postpartum family planning, specifically among women under 25 who have given birth within the last year.

Conditions

  • Depression, Postpartum
  • Anxiety, Postpartum
  • Contraceptive Usage

Interventions

BEHAVIORAL

Mother's Time

Mother's Time is an evidence-based cognitive behavioral therapy (CBT) tool designed to support postpartum women experiencing mild to moderate symptoms of stress, depression, or anxiety. The intervention is designed for use by Ethiopian community health workers (CHWs) and includes CBT exercises and discussion on topics relating to family planning, such as planning for the future, speaking to the husband, and considering potential side effects.

Sponsors & Collaborators

  • United States Agency for International Development (USAID)

    collaborator FED
  • Johns Hopkins Center for Communication Programs

    collaborator UNKNOWN
  • Camber Collective

    collaborator OTHER
  • DeepDive Consulting

    collaborator UNKNOWN
  • Johns Hopkins Bloomberg School of Public Health

    lead OTHER

Principal Investigators

  • Stella Babalola, PhD · Johns Hopkins Bloomberg School of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
24 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-04
Primary Completion
2023-10-30
Completion
2023-12-31

Countries

  • Ethiopia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05806463 on ClinicalTrials.gov